Gene · 3832
Papers3,579
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,579
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Deciphering molecular landscape of breast cancer progression and insights from functional genomics and therapeutic explorations followed by in vitro validation. | Sci Rep | 2024 | 39567714 | PubTator, text mining | PubMed |
| Pan-cancer analysis of oncogenic role of CEP55 and experiment validation in clear cell renal cell carcinoma. | Sci Rep | 2024 | 39550427 | PubTator, text mining | PubMed |
| Exploring B-cell epitope conservation and antigenicity shift in current COVID-19 variants: Analyzing spike-antibody interactions for therapeutic uses. | Biochem Biophys Res Commun | 2024 | 39531907 | PubTator, text mining | PubMed |
| [Clinical phenotype and genetic analysis of a child with partial duplication of 10q and a literature review]. | Zhonghua Yi Xue Yi Chuan Xue Za Zhi | 2024 | 39528289 | PubTator, text mining | PubMed |
| Transport of Golgi-localized β-catenin p-S47 by KIF11 or KIFC3 induces primary ciliogenesis. | Mol Cells | 2024 | 39476973 | PubTator, text mining | PubMed |
| Key genes and pathways in the molecular landscape of pancreatic ductal adenocarcinoma: A bioinformatics and machine learning study. | Comput Biol Chem | 2024 | 39467488 | PubTator, text mining | PubMed |
| Identification and evaluation of candidate COVID-19 critical genes and medicinal drugs related to plasma cells. | BMC Infect Dis | 2024 | 39363208 | PubTator, text mining | PubMed |
| Highlighting multicomponent reactions as an efficient and facile alternative route in the chemical synthesis of organic-based molecules: a tremendous growth in the past 5 years. | Front Chem | 2024 | 39359421 | PubTator, text mining | PubMed |
| Decoding the immune microenvironment: unveiling CD8 + T cell-related biomarkers and developing a prognostic signature for personalized glioma treatment. | Cancer Cell Int | 2024 | 39354483 | PubTator, text mining | PubMed |
| Integrated bioinformatic analysis reveals the gene signatures, epigenetic roles, and regulatory networks in endometriosis. | Eur J Obstet Gynecol Reprod Biol | 2024 | 39306912 | PubTator, text mining | PubMed |
| MG53 suppresses tumor growth via transcriptional inhibition of KIF11 in pancreatic cancer. | Transl Oncol | 2024 | 39265509 | PubTator, text mining | PubMed |
| A novel tumor-derived exosomal gene signature predicts prognosis in patients with pancreatic cancer. | Transl Cancer Res | 2024 | 39262474 | PubTator, text mining | PubMed |
| Tourism promotion during emergency response to Omicron subvariant outbreak. | Heliyon | 2024 | 39258205 | PubTator, text mining | PubMed |
| Corrigendum to "Monastrol suppresses invasion and metastasis in human colorectal cancer cells by targeting fascin independent of kinesin-Eg5 pathway" [Biomed. Pharmacother. 175 (2024) 116785]. | Biomed Pharmacother | 2024 | 39256102 | PubTator, text mining | PubMed |
| Transcriptomic landscape of quiescent and proliferating human corneal stromal fibroblasts. | Exp Eye Res | 2024 | 39243928 | PubTator, text mining | PubMed |
| Esophageal chemical burns as a risk factor for esophageal malignancies: in-silico analyses - experimental research. | Ann Med Surg (Lond) | 2024 | 39239040 | PubTator, text mining | PubMed |
| Teaching old docks new tricks with machine learning enhanced ensemble docking. | Sci Rep | 2024 | 39237737 | PubTator, text mining | PubMed |
| Retraction Note: The kinesin Eg5 inhibitor K858 induces apoptosis but also survivin-related chemoresistance in breast cancer cells. | Invest New Drugs | 2024 | 39212894 | PubTator, text mining | PubMed |
| Definition of a concentration and RNA extraction protocol for optimal whole genome sequencing of SARS-CoV-2 in wastewater (ANRS0160). | Sci Total Environ | 2024 | 39197764 | PubTator, text mining | PubMed |
| Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation (MCLMR)- the new lacunae: a case report. | BMC Ophthalmol | 2024 | 39187757 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3832/papers?page=11